Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China

[1] Dienstag JL(2008)Hepatitis B virus infection N Engl J Med. 359 1486-1500

[2] Wei L(2013)A novel estimation of the impact of treatment with entecavir on long-term mortality, morbidity, and health care costs of chronic hepatitis B in China Value Health Reg Issue. 2 48-56

[3] Hu SL(2009)Hepatitis B virus DNA levels and outcomes in chronic hepatitis B Hepatology. 49 S72-S84

[4] Hou JL(2002)Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med. 347 168-174

[5] Liu GG(2002)Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B Hepatology. 35 1522-1527

[6] Ren H(2012)Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B Liver Int. 32 137-146

[7] Duan ZP(2009)A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China J Dig Dis. 10 131-137

[8] Chen CJ(2011)Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome J Hepatol. 55 522-528

[9] Yang HI(2012)Management of chronic hepatitis B virus infection J Hepatol. 57 167-185

[10] Iloeje UH(2009)Chronic hepatitis B: update 2009 Hepatology. 50 661-662

[1] Dienstag JL(2008)Hepatitis B virus infection N Engl J Med. 359 1486-1500

[2] Wei L(2013)A novel estimation of the impact of treatment with entecavir on long-term mortality, morbidity, and health care costs of chronic hepatitis B in China Value Health Reg Issue. 2 48-56

[3] Hu SL(2009)Hepatitis B virus DNA levels and outcomes in chronic hepatitis B Hepatology. 49 S72-S84

[4] Hou JL(2002)Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med. 347 168-174

[5] Liu GG(2002)Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B Hepatology. 35 1522-1527

[6] Ren H(2012)Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B Liver Int. 32 137-146

[7] Duan ZP(2009)A 7-year study of lamivudine therapy for hepatitis B virus e antigen-positive chronic hepatitis B patients in China J Dig Dis. 10 131-137

[8] Chen CJ(2011)Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome J Hepatol. 55 522-528

[9] Yang HI(2012)Management of chronic hepatitis B virus infection J Hepatol. 57 167-185

[10] Iloeje UH(2009)Chronic hepatitis B: update 2009 Hepatology. 50 661-662